**WINTER OF WOE - BONUS OBJECTIVE POINT**
As previously announced, the team will be distributing an additional point toward milestones to anyone who completed the Absorbing Man fight in the first step of the Winter of Woe.
This point will be distributed at a later time as it requires the team to pull and analyze data.
The timeline has not been set, but work has started.
There is currently an issue where some Alliances are are unable to find a match in Alliance Wars, or are receiving Byes without getting the benefits of the Win. We will be adjusting the Season Points of the Alliances that are affected within the coming weeks, and will be working to compensate them for their missed Per War rewards as well.

Additionally, we are working to address an issue where new Members of an Alliance are unable to place Defenders for the next War after joining. We are working to address this, but it will require a future update.

Who to 4/55 Venom or Iceman?

Both are unawakened at the moment. Thank you to anyone who votes/gives input

Who to 4/55 Venom or Iceman? 30 votes

Venom
43% 13 votes
Iceman
56% 17 votes

Comments

  • Hammerbro_64Hammerbro_64 Posts: 7,463 ★★★★★
    That’s a toughie. Can u post your roster?
  • Akib35Akib35 Posts: 11
    uv53c9sheeix.jpeg
    3mzbrqgix2v3.jpeg
  • Akib35Akib35 Posts: 11
    Note: Venom only doesn't have the blue arrow right now because i haven't opened my t4cc crystals and I only need 200 more frags so ignore that
  • ezgoingezgoing Posts: 269 ★★
    Considering you don’t seem to have any good immune options, iceman for his triple immunity will be my choice. And unless T2a isn’t an issue for you, but you are overflowing with cosmic t4cc, I will also wait to go for starlord.
  • Hammerbro_64Hammerbro_64 Posts: 7,463 ★★★★★
    I would maybe say Iceman unless you don’t like voodoo as a buff controller. You’ve already got KM for evasion and autoblock (tho maybe venom concerning IMIW) overall I guess Iceman is the better choice for now. Venom can go up once you get more cats. (Or SL)
Sign In or Register to comment.